![]() |
Volumn 158, Issue 6, 1998, Pages 1697-1698
|
Should antileukotriene therapies be used instead of inhaled corticosteroids in asthma? Yes. Editorial
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ARACHIDONATE 5 LIPOXYGENASE;
CORTICOSTEROID;
LEUKOTRIENE;
LEUKOTRIENE RECEPTOR BLOCKING AGENT;
MONTELUKAST;
PRANLUKAST;
ZAFIRLUKAST;
ZILEUTON;
ASTHMA;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
EDITORIAL;
FORCED EXPIRATORY VOLUME;
LUNG FUNCTION;
PATIENT COMPLIANCE;
PATIENT SATISFACTION;
PRACTICE GUIDELINE;
PREVALENCE;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
ANTIINFLAMMATORY ACTIVITY;
BRONCHODILATATION;
BRONCHUS HYPERREACTIVITY;
CHURG STRAUSS SYNDROME;
GASTROINTESTINAL DISEASE;
HEALTH CARE COST;
INFLAMMATION;
LIVER TOXICITY;
QUALITY OF LIFE;
|
EID: 0032427719
PISSN: 1073449X
EISSN: None
Source Type: Journal
DOI: 10.1164/ajrccm.158.6.15860 Document Type: Editorial |
Times cited : (32)
|
References (15)
|